Co-Diagnostics Profit Margin

Co-Diagnostics (CODX) currently reports a profit margin of -6523.04% as of June 2026. That compares with -3586.0% in the prior-year period — down 81.9% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Co-Diagnostics's profit margin history and peer comparisons.

Co-Diagnostics's profit margin decreased from -3586.0% to -6523.04% — a 81.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Co-Diagnostics's profit margin of -6523.04% is lower than the Healthcare sector average of 21.34%. That is roughly 30674.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Co-Diagnostics's current -6523.04% should be judged against Healthcare norms (sector average: 21.34%) and against CODX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -6523.04%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Co-Diagnostics, and consider following CODX for alerts when major investors trade the stock.